Abstract
In two population-based cohorts, we did not find an independent relationship between albuminuria and ILA, with age emerging as a key confounding factor. Our results suggest there may be a common systemic pathology of aging that underlies albuminuria and ILA.Background: Pulmonary microvascular dysfunction has been suggested to be an early feature of interstitial lung changes, which may precede interstitial lung disease (ILD). The prospective association of albuminuria, a marker of endothelial dysfunction, with interstitial lung abnormalities (ILA) and high-attenuation areas (HAA) remains unexplored.Methods: The study included participants with available spot urinary albumin-creatinine ratio (UACR) and CT data for ILA and HAA enrolled in two independent cohorts, MESA (Multi-Ethnic Study of Atherosclerosis; n=2 248) and AGES-Reykjavik (Age, Gene/Environment Susceptibility-Reykjavik; n=3509). HAA were defined as the percentage of imaged lungs with attenuation between −600 and −250 Hounsfield units (MESA only). Regression modeling was performed to assess the associations of UACR with ILA and HAA, adjusted for anthropometric and demographic variables and kidney function. Cox proportional-hazard models were used to examine whether ILA modified the association between albuminuria and all-cause mortality.Results: Log-transformed UACR was significantly associated with ILA, with an odds ratio (OR) of 1.21 (95% CI, 1.12–1.30) in MESA and OR 1.13 (95% CI, 1.06–1.21) in AGES-Reykjavik. In multivariable-adjusted models incorporating age, albuminuria was no longer associated with ILA, nor with ILA progression in AGES-Reykjavik. In MESA, higher levels of albuminuria were associated with greater HAA (mean increase of 1.02% per 1-unit increment in log-transformed UACR, 95% CI, 1.01–1.02%), even after adjusting for covariates including age. Albuminuria was more strongly associated with death among those with ILA in MESA but not in AGES-Reykjavik.Conclusions: Albuminuria was not associated with ILA after accounting for chronological age. Our findings suggest that there may be a common systemic pathology of aging that underlies albuminuria and interstitial lung changes.
Funding Information
  • Landspitali Scientific Fund (A-2019-029, A-2019-030, A-2020-017, A-2020-018, A2021-018)
  • National Heart, Lung, and Blood Institute (3R01HL-117626-02S1, 3U54HG003067-13S1, HHSN2682015000031, HHSN268201600034I, HHSN268201800001I, HHSN268201800002I, HSN26800004, R01-HL103676, R01-HLO77612, R01HL-120393, RC1-HL100542, U01HL-120393)
  • National Institute on Aging (HHSN27120120022C, N01-AG-1-2100)
  • Icelandic Research Fund (141513-051)
  • National Center for Advancing Translational Sciences (UL1-TR-000040, UL1-TR-001079, UL1-TR-001420, UL1TR001881)

This publication has 42 references indexed in Scilit: